Vol 65, No 6 (2015)

Date published: 2016-02-09

Table of Contents

open access

Original article

The efficacy and safety of trabectedin in patients with advanced liposarcomas and leiomyosarcomas (L-sarcomas)

Hanna Koseła-Paterczyk, Katarzyna Kozak, Anna Klimczak, Tomasz Świtaj, Piotr Rutkowski

Research paper (original)

DOI: 10.5603/NJO.2015.0090
Nowotwory. Journal of Oncology 2015;65(6):451-457.

Evaluation of early breast cancer treatment effects and prognostic factors with special reference to steroid and HER2 receptors

Jacek Gałecki, Marta Olszyna-Serementa, Anna Majstrak, Katarzyna Wiśniowska, Mateusz Spałek, Wojciech Michalski

Research paper (original)

DOI: 10.5603/NJO.2015.0091
Nowotwory. Journal of Oncology 2015;65(6):458-464.
Editorial
Recommendations

Recommendations for diagnosis and therapy of cutaneous melanoma

Piotr Rutkowski, Piotr J. Wysocki, Anna Nasierowska-Guttmejer, Jacek Fijuth, Ewa Kalinka-Warzocha, Tomasz Świtaj, Arkadiusz Jeziorski, Milena Szacht, Wojciech Zegarski, Wojciech M. Wysocki, Lidia Rudnicka, Witold Owczarek, Maciej Krzakowski

Guidelines / Expert consensus

DOI: 10.5603/NJO.2015.0106
Nowotwory. Journal of Oncology 2015;65(6):501-516.
Review article

Ruthenium coordination compounds as drugs in modern anticancer therapy

Urszula Śliwińska-Hill, Joanna Celmer

Review paper

DOI: 10.5603/NJO.2015.0107
Nowotwory. Journal of Oncology 2015;65(6):517-528.
Oncological debates

Disadvantage of overuse of granulocyte-colony stimulating factors (G-CSF) in systematic anticancer treatment

Joanna Połowinczak-Przybyłek, Piotr Potemski

DOI: 10.5603/NJO.2015.0109
Nowotwory. Journal of Oncology 2015;65(6):535-538.
Discussion forum

Journal Impact Factor (JIF): The Good, the Bad, and the Ugly

Jerzy W. Kupiec-Weglinski

Nowotwory. Journal of Oncology 2015;65(6):481-482.

Czy mamy alternatywy dla IF?

Krzysztof J. Filipiak

Nowotwory. Journal of Oncology 2015;65(6):486-487.

Comment to article by prof. Towpik

Malgorzata Blicharska

Nowotwory. Journal of Oncology 2015;65(6):491.

Lies, damned lies, and impact factor

Ana Marušić

Nowotwory. Journal of Oncology 2015;65(6):496-497.
Case report

Pushing the age limit and reducing the number of contraindications of liver resections in cancer-bearing patients — a case report

Konrad Kobryń, Łukasz Masior, Michał Grąt, Bogusław Najnigier, Paweł Nyckowski, Waldemar Patkowski, Marek Krawczyk

Case report

DOI: 10.5603/NJO.2015.0110
Nowotwory. Journal of Oncology 2015;65(6):539-542.
Varia

80-lecie odsłonięcia pomnika Marii Skłodowskiej-Curie przed Instytutem Radowym

Edward Towpik

Other materials agreed with the Editors

DOI: 10.5603/NJO.2015.0111
Nowotwory. Journal of Oncology 2015;65(6):543-545.
In memoriam

Dr n. med. Janusz Pluta

Piotr Pluta

Obituary

DOI: 10.5603/NJO.2015.0112
Nowotwory. Journal of Oncology 2015;65(6):546-547.
Reports

XII Usteckie Dni Onkologiczne

Zoran Stojčev

Conference report / Report

DOI: 10.5603/NJO.2015.0113
Nowotwory. Journal of Oncology 2015;65(6):548-550.
Current events in Polish oncology

Nagroda im. Hilarego Koprowskiego

Other materials agreed with the Editors

DOI: 10.5603/NJO.2015.0114
Nowotwory. Journal of Oncology 2015;65(6):551.
Journal Club

Journal Club

Anna Kowalczyk, Ewa Szutowicz-Zielińska, Anna Wrona, Krzysztof Konopa

Other materials agreed with the Editors

Nowotwory. Journal of Oncology 2015;65(6):552-558.
Announcements

Komunikaty

Announcement

Nowotwory. Journal of Oncology 2015;65(6):559-561.



Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl